Literature DB >> 21999927

Death receptor signalling in central nervous system inflammation and demyelination.

Conor Mc Guire1, Rudi Beyaert, Geert van Loo.   

Abstract

Death receptors (DRs) are members of the tumor necrosis factor receptor (TNF-R) superfamily that are characterised by the presence of a conserved intracellular death domain and are able to trigger a signalling pathway leading to apoptosis. Strong evidence suggests that DRs contribute to the pathology of tissue destructive diseases, including multiple sclerosis (MS), the most common inflammatory demyelinating disease of the central nervous system (CNS). Here, we review the evidence supporting a role for DRs in MS pathology and its implications for the development of therapeutic strategies for MS and other demyelinating pathologies of the CNS.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21999927     DOI: 10.1016/j.tins.2011.09.002

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  24 in total

1.  Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells.

Authors:  Zizhen Kang; Chenhui Wang; Jarod Zepp; Ling Wu; Kevin Sun; Junjie Zhao; Unni Chandrasekharan; Paul E DiCorleto; Bruce D Trapp; Richard M Ransohoff; Xiaoxia Li
Journal:  Nat Neurosci       Date:  2013-09-01       Impact factor: 24.884

2.  Implicating Receptor Activator of NF-κB (RANK)/RANK Ligand Signalling in Microglial Responses to Toll-Like Receptor Stimuli.

Authors:  Anton Kichev; Pascale Eede; Pierre Gressens; Claire Thornton; Henrik Hagberg
Journal:  Dev Neurosci       Date:  2017-04-13       Impact factor: 2.984

3.  RIP1 Inhibition Rescues from LPS-Induced RIP3-Mediated Programmed Cell Death, Distributed Energy Metabolism and Spatial Memory Impairment.

Authors:  Sara Nikseresht; Fariba Khodagholi; Mohsen Nategh; Leila Dargahi
Journal:  J Mol Neurosci       Date:  2015-07-09       Impact factor: 3.444

4.  Blockade of tumour necrosis factor-α in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology.

Authors:  H Batoulis; M S Recks; F O Holland; F Thomalla; R O Williams; S Kuerten
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

5.  Accumulation of reactivity to MBP sensitizes TRAIL mediated oligodendrocyte apoptosis in adult sub cortical white matter in a model for human multiple sclerosis.

Authors:  Sajad Mir; Farrah Ali; Deepika Chauhan; Rajesh Arora; Haider A Khan
Journal:  Metab Brain Dis       Date:  2015-10-19       Impact factor: 3.584

6.  An integrative microfluidically supported in vitro model of an endothelial barrier combined with cortical spheroids simulates effects of neuroinflammation in neocortex development.

Authors:  Martin Raasch; Knut Rennert; Tobias Jahn; Claudia Gärtner; Gilbert Schönfelder; Otmar Huber; Andrea E M Seiler; Alexander S Mosig
Journal:  Biomicrofluidics       Date:  2016-07-05       Impact factor: 2.800

7.  Mesenchymal stromal cells attenuate multiple sclerosis via IDO-dependent increasing the suppressive proportion of CD5+ IL-10+ B cells.

Authors:  Huijuan Li; Yinan Deng; Jinliang Liang; Feng Huang; Wei Qiu; Min Zhang; Youming Long; Xueqiang Hu; Zhengqi Lu; Wei Liu; Song Guo Zheng
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

8.  HTLV-1-infected asymptomatic carriers compared to HAM/TSP patients over-express the apoptosis- and cytotoxicity-related molecules.

Authors:  Asadollah Mohammadi; Bahare Fazeli; Zohreh Poursina; Farahnaz Tehranian; Veda Vakili; Reza Boostani; Houshang Rafatpanah
Journal:  Med Microbiol Immunol       Date:  2019-07-18       Impact factor: 3.402

Review 9.  A further TWEAK to multiple sclerosis pathophysiology.

Authors:  Arash Nazeri; Pouria Heydarpour; Shokufeh Sadaghiani; Mohammad Ali Sahraian; Linda C Burkly; Amit Bar-Or
Journal:  Mol Neurobiol       Date:  2013-07-20       Impact factor: 5.590

10.  Platelets induce apoptosis via membrane-bound FasL.

Authors:  Rebecca I Schleicher; Frank Reichenbach; Peter Kraft; Anil Kumar; Mario Lescan; Franziska Todt; Kerstin Göbel; Ingo Hilgendorf; Tobias Geisler; Axel Bauer; Marcus Olbrich; Martin Schaller; Sebastian Wesselborg; Lorraine O'Reilly; Sven G Meuth; Klaus Schulze-Osthoff; Meinrad Gawaz; Xuri Li; Christoph Kleinschnitz; Frank Edlich; Harald F Langer
Journal:  Blood       Date:  2015-07-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.